"The Institute of Neurology and Neurosurgery at Saint Barnabas is dedicated to providing state-of-the-art diagnosis and treatment of neurological conditions for Livingston, NJ, and the surrounding communities."

During the past decade, Institute of Neurology and Neurosurgery at St. Barnabas conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institute of Neurology and Neurosurgery at St. Barnabas" #1 sponsor was "Marinus Pharmaceuticals" with 2 trials, followed by "Takeda" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Enzymotec" with 1 trials sponsored and "NYU Langone Health" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Neurology and Neurosurgery at St. Barnabas" #1 collaborator was "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator, "St. Barnabas Medical Center" with 1 trials as a collaborator and "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Neurology and Neurosurgery at St. Barnabas" are "Epilepsy" (2 trials), "Lennox Gastaut Syndrome" (2 trials), "Lennox Gastaut Syndrome (LGS)" (2 trials), "Autistic Disorder" (1 trials) and "Dravet Syndrome" (1 trials). Many other conditions were trialed in "Institute of Neurology and Neurosurgery at St. Barnabas" in a lesser frequency.

Most popular intervention types in "Institute of Neurology and Neurosurgery at St. Barnabas" are "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Soticlestat" (2 trials), "Ganaxalone" (1 trials), "Ganaxolone" (1 trials) and "Lorcaserin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Neurology and Neurosurgery at St. Barnabas" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Neurology and Neurosurgery at St. Barnabas". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Institute of Neurology and Neurosurgery at St. Barnabas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Neurology and Neurosurgery at St. Barnabas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".